Common Splendor International Health Industry Group Limited provides earnings guidance for the six months ended June 30, 2017. For the period, the company expects to record a reduction of approximately 70% in profit before tax as compared to the profit before tax for the corresponding period in 2016 of HKD 41.5 million. Such reduction in profit was mainly attributable to the substantial increase of finance costs of approximately HKD 12.8 million arising from the issue of convertible notes, guaranteed notes and bonds by the Company; and the absence of a one-off gain on disposal of an associate as compared to the corresponding period in 2016, where the Group recorded a gain on disposal of an associate of HKD 28.6 million.